Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

30.54
Delayed Data
As of 4:00pm ET
 -0.66 / -2.12%
Today’s Change
18.55
Today|||52-Week Range
245.82
-69.96%
Year-to-Date
Healthcare Drug Pricing a Factor for the Market on Wednesday
6:13pm / GuruFocus News - Paid Partner Content
Buy Valeant Stock for a 45% Profit? 3 Things You Need to Know
Aug 17 / MotleyFool.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
4:09pm / TheStreet.com - Paid Partner Content
2 Stocks Bill Ackman Is Dumping
Aug 17 / MotleyFool.com - Paid Partner Content
Crude Oil, Health Care Team Up to Pull Wall Street Lower
4:09pm / TheStreet.com - Paid Partner Content
Morgan Stanley Says It's Time to Buy Valeant Again
Aug 17 / TheStreet.com - Paid Partner Content
4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnar...
Aug 23 / MotleyFool.com - Paid Partner Content
Stocks Fall on Retail Disappointments as Wall Street Awaits Fed Minutes
Aug 17 / TheStreet.com - Paid Partner Content
Stock Market News for August 23, 2016
Aug 23 / Zacks.com - Paid Partner Content
Valeant Shares Spike as Morgan Stanley Analysts Go Bullish Again
Aug 17 / TheStreet.com - Paid Partner Content
Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today
Aug 22 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Soars After Ratings Upgrade
Aug 17 / TheStreet.com - Paid Partner Content
Stocks Waver as Investors Wait for Fed Clarity
Aug 22 / TheStreet.com - Paid Partner Content
Dead Companies Walking: An Interesting Book on Short Selling
Aug 16 / GuruFocus News - Paid Partner Content
Valeant's C-Suite Sees Another Shake-Up
Aug 22 / TheStreet.com - Paid Partner Content
Hey, Valeant Pharmaceuticals, Less Bad Still Isn't Good
Aug 16 / MotleyFool.com - Paid Partner Content
Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%
Aug 22 / Zacks.com - Paid Partner Content
Jim Cramer: Hain Celestial's Accounting Irregularities Could Be 'Grim'
Aug 16 / TheStreet.com - Paid Partner Content
Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO
Aug 22 / TheStreet.com - Paid Partner Content
Cramer: How Do You Handle a Problem Like Hain?
Aug 16 / TheStreet.com - Paid Partner Content
Allergan Makes an Eye-Opening Acquisition
Aug 22 / MotleyFool.com - Paid Partner Content
10 Best-Performing Stocks This Earnings Season
Aug 16 / TheStreet.com - Paid Partner Content
Morning Movers: PFE, VRX, VIAB, FL, UA
Aug 22 / TheStreet.com - Paid Partner Content
Trending Tickers: VRX, TWTR, ACIA, BBY
Aug 15 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFO
Aug 22 / TheStreet.com - Paid Partner Content
CNBC's 'Halftime Report' Panel Debates Valeant (VRX) Stock After Mizuho Ratings Upgra...
Aug 15 / TheStreet.com - Paid Partner Content
HAIN, AMZN, WFM: Jim Cramer's Views
Aug 22 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals (VRX) Stock Gains, Mizuho Upgrades
Aug 15 / TheStreet.com - Paid Partner Content
Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof
Aug 19 / MotleyFool.com - Paid Partner Content
Valeant's Latest Problems Are a Red Flag for Investors
Aug 15 / TheStreet.com - Paid Partner Content
Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan
Aug 19 / Zacks.com - Paid Partner Content
Overboarded Directors at Valeant, Yahoo! and Elsewhere Struggle With Activists, M&A
Aug 12 / TheStreet.com - Paid Partner Content
Company News for August 19, 2016
Aug 19 / Zacks.com - Paid Partner Content
Francis Chou Adds to 2 Positions in 2nd Quarter
Aug 12 / GuruFocus News - Paid Partner Content
Valeant (VRX) Stock Falls on T. Rowe Price Lawsuit
Aug 18 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Up, Wells Fargo: Analysts Missing Lower Outlook
Aug 12 / TheStreet.com - Paid Partner Content
Wells Fargo Analyst Maris Weighs In on Valeant (VRX) Lawsuit on CNBC
Aug 18 / TheStreet.com - Paid Partner Content
Why Shake Shack, Amarin, and Valeant Pharmaceuticals Slumped Today
Aug 11 / MotleyFool.com - Paid Partner Content
Take the Pain and Exit Hain
Aug 18 / TheStreet.com - Paid Partner Content
Valeant's Legal Woes Aren't New, but They Are Mounting
Aug 11 / MotleyFool.com - Paid Partner Content
Stocks Struggle for Gains as Crude Oil Rallies for Sixth Session
Aug 18 / TheStreet.com - Paid Partner Content
Criminal Probe Pushes Valeant Pharmaceuticals Stock Down Nearly 11%
Aug 11 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Higher on Credit Facility Amendment
Aug 18 / TheStreet.com - Paid Partner Content
If You Own Valeant (VRX) Stock, You May Want to Sell Now
Aug 11 / Zacks.com - Paid Partner Content
Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals J...
Aug 17 / MotleyFool.com - Paid Partner Content
Can Anything More Go Wrong for Valeant?
Aug 11 / MotleyFool.com - Paid Partner Content
Choppy Session Ends Higher After Minutes Show Divided Fed
Aug 17 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals Is Dangerously Close to Violating its Debt Covenants
Aug 10 / MotleyFool.com - Paid Partner Content
Trending Tickers: CIT, VRX, BWLD, BKS
Aug 17 / TheStreet.com - Paid Partner Content
Here's How Valeant Pharmaceuticals Hopes to Get Back on Track
Aug 09 / MotleyFool.com - Paid Partner Content